Ninds drug manufacturing and formulation program (dmfp)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N98026D00013
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Drug Manufacturing and Formulation Program (DMFP) Pre-Solicitation · 75N95024R00077 · Posted May 3, 2024
- Last date to order 5% complete
- IDV ceiling
- $49,999,999.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Neurological Disorders and Stroke awarded a multiple-award indefinite-delivery contract to Curia Global Inc. (doing business as Amri) on May 4, 2026, with a ceiling of $49,999,999 and an ultimate completion date of May 3, 2036.
The contract carries no set-aside designation and is open to all qualified contractors. Place of performance is not specified in the source.
The originating solicitation, posted May 3, 2024, sought drug manufacturing and formulation services to support the Drug Manufacturing and Formulation Program (DMFP), a component of the Blueprint Neurotherapeutics Network (BPN). The procurement targets API scale-up and manufacturing, formulation and dosage form manufacturing, analytical methods development, and stability testing to enable candidate molecules to enter clinical-stage development. The contract includes a Determination of Exceptional Circumstances provision allowing contributors to retain intellectual property control for investigational agents evaluated through the DMFP.
The IDIQ carries a ten-year ordering period. This is one of multiple awards issued under the DMFP solicitation. The anticipated awards were originally scheduled for January 2025; this award reflects a subsequent timeline.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N98026D00013?
75N98026D00013 was awarded to Curia Global Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on May 4, 2026.
How much is contract 75N98026D00013 worth?
75N98026D00013's own ceiling is $49,999,999.
Which agency awarded contract 75N98026D00013?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026D00013, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Who can order from contract 75N98026D00013?
75N98026D00013 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N98026D00013 competed?
The extent of competition for 75N98026D00013 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV